BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24114443)

  • 41. Stability of enzymes in starving Arthrobacter crystallopoietes.
    Meganathan R; Ensign JC
    J Gen Microbiol; 1976 May; 94(1):90-6. PubMed ID: 180237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolite sensing and signaling in cancer.
    Wang YP; Li JT; Qu J; Yin M; Lei QY
    J Biol Chem; 2020 Aug; 295(33):11938-11946. PubMed ID: 32641495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H.
    Yang B; Zhong C; Peng Y; Lai Z; Ding J
    Cell Res; 2010 Nov; 20(11):1188-200. PubMed ID: 20975740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice.
    Kim S; Kim SY; Ku HJ; Jeon YH; Lee HW; Lee J; Kwon TK; Park KM; Park JW
    Biochim Biophys Acta; 2014 Feb; 1842(2):135-43. PubMed ID: 24240089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Addressing the Core of Carcinogenesis: How a Mitochondrial Mutation Leads to Metabolic Remodeling in Familial Cancers.
    De Flora A; De Flora S
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26719883
    [No Abstract]   [Full Text] [Related]  

  • 46. A systems approach to predict oncometabolites via context-specific genome-scale metabolic networks.
    Nam H; Campodonico M; Bordbar A; Hyduke DR; Kim S; Zielinski DC; Palsson BO
    PLoS Comput Biol; 2014 Sep; 10(9):e1003837. PubMed ID: 25232952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-translational modifications and the Warburg effect.
    Hitosugi T; Chen J
    Oncogene; 2014 Aug; 33(34):4279-85. PubMed ID: 24096483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Terminal oxidation pathways in propionic acid bacteria].
    Bonartseva GA; Kraĭnova OA; Vorob'eva LI
    Mikrobiologiia; 1973; 42(4):583-8. PubMed ID: 4151565
    [No Abstract]   [Full Text] [Related]  

  • 49. Succinate dehydrogenase/complex II is critical for metabolic and epigenetic regulation of T cell proliferation and inflammation.
    Chen X; Sunkel B; Wang M; Kang S; Wang T; Gnanaprakasam JNR; Liu L; Cassel TA; Scott DA; Muñoz-Cabello AM; Lopez-Barneo J; Yang J; Lane AN; Xin G; Stanton BZ; Fan TW; Wang R
    Sci Immunol; 2022 Apr; 7(70):eabm8161. PubMed ID: 35486677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymes of the tricarboxylic acid cycle in Ancylostoma ceylanicum and Nippostrongylus brasiliensis.
    Singh SP; Katiyar JC; Srivastava VM
    J Parasitol; 1992 Feb; 78(1):24-9. PubMed ID: 1738065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolite-driven antitumor immunity.
    Nathan JA
    Science; 2022 Sep; 377(6614):1488-1489. PubMed ID: 36173838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation.
    Brière JJ; Favier J; Gimenez-Roqueplo AP; Rustin P
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1114-20. PubMed ID: 16760265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deep epistasis in human metabolism.
    Imielinski M; Belta C
    Chaos; 2010 Jun; 20(2):026104. PubMed ID: 20590333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer metabolism: key players in metabolic reprogramming.
    Soga T
    Cancer Sci; 2013 Mar; 104(3):275-81. PubMed ID: 23279446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities.
    Zhang C; Zhang F
    Protein Cell; 2015 Feb; 6(2):88-100. PubMed ID: 25476483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Interplay between Dysregulated Metabolism and Epigenetics in Cancer.
    Bassal MA
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The Warburg effect: from theory to therapeutic applications in cancer].
    Razungles J; Cavaillès V; Jalaguier S; Teyssier C
    Med Sci (Paris); 2013 Nov; 29(11):1026-33. PubMed ID: 24280507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncometabolites: tailoring our genes.
    Nowicki S; Gottlieb E
    FEBS J; 2015 Aug; 282(15):2796-805. PubMed ID: 25864878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of metabolic pathways activated in cancer cells as determined through isotopic labeling and network analysis.
    Dong W; Keibler MA; Stephanopoulos G
    Metab Eng; 2017 Sep; 43(Pt B):113-124. PubMed ID: 28192215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting Metabolism for Cancer Therapy.
    Luengo A; Gui DY; Vander Heiden MG
    Cell Chem Biol; 2017 Sep; 24(9):1161-1180. PubMed ID: 28938091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.